Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KK.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KK.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KK.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KK.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.1.4.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FY.1.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.1.4.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FY.1.4.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FY.1.4.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FY.1.4.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FY.1.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.1.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JG.3.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-1649.2South Korea
JG.3.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JG.3.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
JG.3.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JG.3.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JG.3.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JG.3.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JG.3.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.56EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.56EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.56ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.2.56ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.56EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.56EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.56ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.56ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.13EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.2.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.13ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KP.2.13ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KP.2.13EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KP.2.13EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KP.2.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.2.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDP.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XDP.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDP.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XDP.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XDP.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XDP.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used